qs_id,statement_number,statement
QS149,1,Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.
QS149,2,Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.
QS149,3,Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.
QS149,4,Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.
